| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
60,492,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
5,682,564 |
Avg
Vol: |
2,636,078 |
| 52
Week Range: |
$31.96 - $31.96 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bedoya-Toro Maria E |
SVP, Regulatory Affairs & QA |
• – – |
2013-05-08 |
4 |
OE |
$1.18 |
$18,488 |
D/D |
10,000 |
58,593 |
|
- |
|
| Fox Carey J |
Sr VP, General Counsel |
• – – |
2013-05-07 |
4 |
AS |
$20.86 |
$356,781 |
D/D |
(17,100) |
24,134 |
|
- |
|
| Fox Carey J |
Sr VP, General Counsel |
• – – |
2013-05-07 |
4 |
OE |
$1.18 |
$20,178 |
D/D |
17,100 |
41,234 |
|
- |
|
| Step Michael D |
SVP, Corporate Development |
• – – |
2013-05-06 |
4 |
AS |
$18.74 |
$567,701 |
D/D |
(30,301) |
1,497 |
|
- |
|
| Step Michael D |
SVP, Corporate Development |
• – – |
2013-05-06 |
4 |
OE |
$1.18 |
$35,755 |
D/D |
30,301 |
31,798 |
|
- |
|
| Proehl Gerald T |
President & CEO |
• • – |
2013-05-06 |
4 |
AS |
$18.73 |
$1,622,464 |
D/D |
(86,603) |
74,137 |
|
- |
|
| Proehl Gerald T |
President & CEO |
• • – |
2013-05-06 |
4 |
OE |
$0.88 |
$75,778 |
D/D |
86,603 |
160,740 |
|
- |
|
| Hall Warren E |
Sr. VP, Mfg. & Prod. Dev. |
• – – |
2013-05-03 |
4 |
AS |
$18.89 |
$543,074 |
D/D |
(28,749) |
9,691 |
|
- |
|
| Hall Warren E |
Sr. VP, Mfg. & Prod. Dev. |
• – – |
2013-05-03 |
4 |
OE |
$3.50 |
$97,629 |
D/D |
27,894 |
38,440 |
|
- |
|
| Ballard E David Ii |
SVP, Med Affairs & Pharmvig |
• – – |
2013-05-02 |
4 |
AS |
$18.45 |
$166,027 |
D/D |
(9,000) |
0 |
|
- |
|
| Ballard E David Ii |
SVP, Med Affairs & Pharmvig |
• – – |
2013-05-02 |
4 |
OE |
$1.18 |
$10,620 |
D/D |
9,000 |
9,000 |
|
- |
|
| Burgess Daniel D |
Director |
– • – |
2013-05-01 |
4 |
AS |
$17.88 |
$143,047 |
D/D |
(8,000) |
0 |
|
- |
|
| Burgess Daniel D |
Director |
– • – |
2013-05-01 |
4 |
OE |
$3.00 |
$24,000 |
D/D |
8,000 |
8,000 |
|
- |
|
| Denby William C |
Sr. VP, Commercial Operations |
• – – |
2013-05-01 |
4 |
AS |
$17.90 |
$437,623 |
D/D |
(24,450) |
0 |
|
- |
|
| Denby William C |
Sr. VP, Commercial Operations |
• – – |
2013-05-01 |
4 |
OE |
$3.50 |
$68,593 |
D/D |
19,598 |
24,450 |
|
- |
|
| Crawford Debra P |
Sr. VP, CFO, Secy, Treas |
• – – |
2013-04-10 |
4 |
AS |
$16.82 |
$319,563 |
D/D |
(19,000) |
165,964 |
|
- |
|
| Crawford Debra P |
Sr. VP, CFO, Secy, Treas |
• – – |
2013-04-10 |
4 |
OE |
$3.50 |
$66,500 |
D/D |
19,000 |
184,964 |
|
- |
|
| De Meules Julie A |
Sr. VP, Human Resources |
• – – |
2013-04-09 |
4 |
AS |
$17.06 |
$258,757 |
D/D |
(15,165) |
4,948 |
|
- |
|
| De Meules Julie A |
Sr. VP, Human Resources |
• – – |
2013-04-09 |
4 |
OE |
$5.25 |
$79,616 |
D/D |
15,165 |
20,113 |
|
- |
|
| Bedoya-Toro Maria E |
SVP, Regulatory Affairs & QA |
• – – |
2013-04-08 |
4 |
AS |
$16.70 |
$167,030 |
D/D |
(10,000) |
48,593 |
|
- |
|
| Bedoya-Toro Maria E |
SVP, Regulatory Affairs & QA |
• – – |
2013-04-08 |
4 |
OE |
$1.18 |
$11,800 |
D/D |
10,000 |
58,593 |
|
- |
|
| Fox Carey J |
Sr VP, General Counsel |
• – – |
2013-04-08 |
4 |
AS |
$16.69 |
$285,380 |
D/D |
(17,100) |
24,134 |
|
- |
|
| Fox Carey J |
Sr VP, General Counsel |
• – – |
2013-04-08 |
4 |
OE |
$1.18 |
$20,178 |
D/D |
17,100 |
41,234 |
|
- |
|
| Bedoya-Toro Maria E |
SVP, Regulatory Affairs & QA |
• – – |
2013-04-05 |
4 |
OE |
$1.18 |
$129,948 |
D/D |
42,744 |
48,593 |
|
- |
|
| Proehl Gerald T |
President & CEO |
• • – |
2013-04-04 |
4 |
AS |
$16.75 |
$1,450,151 |
D/D |
(86,601) |
457,707 |
|
- |
|
417 Records found
|
|
Page 7 of 17 |
|
|
